Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-07-054459
Filing Date
2007-10-16
Accepted
2007-10-16 12:12:46
Documents
4
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 v090174_10ka.htm 10-K/A 1148174
2 v090174_ex23-1.htm EX-23.1 4462
3 v090174_ex31-1.htm EX-31.1 14777
4 v090174_ex31-2.htm EX-31.2 15068
  Complete submission text file 0001144204-07-054459.txt   1183969
Mailing Address 221 WEST GRAND AVENUE MONTVALE, NJ 07645
Business Address 221 WEST GRAND AVENUE MONTVALE, NJ 07645 2019345000
Synvista Therapeutics, Inc. (Filer) CIK: 0000878903 (see all company filings)

EIN.: 133304550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16043 | Film No.: 071173576
SIC: 2834 Pharmaceutical Preparations